On March 31, 2023, the Agency for Technical Hospital Information published the 2023 DRG tariffs and tariffs for other packages and supplements.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Otten et al. conducted a comprehensive review of methods for uncertainty assessment in model-based health economic evaluations. The authors identified a total of 80 uncertainty methods and categorized them into identification, analysis, and communication methods. The findings of this review can support analysts and decision-makers in selecting appropriate uncertainty assessment methods for their purposes and stage of assessment.

On April 5, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) announced the selection of thirteen applications for Innovation Funding for the development or further development of the clinical guidelines. A total of 31 applications were received in response to the funding announcement of June 27, 2022, and thirteen of them were accepted.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Gensorowsky et al. reviewed the legal framework and challenges for market access and pricing of digital health applications (DiGA) in German statutory health insurance (SHI) settings. In addition, the authors provided an evidence-based approach to value-based DiGA pricing that considers the positive healthcare effects and approximates the willingness to pay by the sickness funds. The proposed approach can provide objective guidance for price negotiations, although numerous methodological and procedural issues related to DiGA pricing are still unsolved.

In April 2023, NHS England published an updated version of the National Genomic Test Directory for 2023/2024, which lists tests commissioned by NHS England via Genomic Laboratory Hubs. Sixteen new codes (test-indication combinations) were introduced in the Test Directory for cancer, and 25 new codes in the Test Directory for rare and inherited diseases.

On March 31, 2023, the Ministry of Health and Prevention published the Decree in the Official Journal of the French Republic that defines an application process for the early coverage of digital medical devices for therapeutic purposes and medical telemonitoring by health insurance.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Boriani et al. evaluated the expectations and opinions of healthcare professionals in Europe on reimbursement policies for the use of digital devices (including wearables) in atrial fibrillation and other arrhythmias. The study summarized information about the use of digital devices, trust in digital technologies, and availability of reimbursement of digital technologies in individual EU countries.

In April 2023, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) published the updated 2023 version of the assessment framework of the "state of science and practice" criteria, including the assessment framework itself, modules with additional explanations for its application, and other information material.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Drummond et al. analyzed the actual alignment between the current practice of coverage with evidence development (CED) schemes for medical devices in Europe and the theoretical principles proposed by health economists. In addition, the authors provided a series of recommendations that should support decision-makers in developing and conducting CED schemes in the future, as these schemes can provide real-world evidence on the performance of medical devices.

The revised EBM (German Uniform Evaluation Standard) catalog came into force on April 1, 2023. The most significant changes concern introducing the new EBM codes for follow-up and evaluation of the “Invirto” health app, high-frequency endometrium ablation, and reducing the tariff for COVID-19 PCR tests.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Drummond et al. analyzed the actual alignment between the current practice of coverage with evidence development (CED) schemes for medical devices in Europe and the theoretical principles proposed by health economists. In addition, the authors provided a series of recommendations that should support decision-makers in developing and conducting CED schemes in the future, as these schemes can provide real-world evidence on the performance of medical devices.

On March 16, 2023, the Reimbursement Commission of the Social Security Institution (SSI) released an updated version of the Healthcare Implementation Communique (SUT). The main change relates to the increase in reimbursement fees of services and medical devices. Furthermore, eight new cardiovascular procedure codes were introduced.